Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Algorae Pharmaceticls Ltd (LVCLF)

Algorae Pharmaceticls Ltd (LVCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Algorae Pharmaceticls Ltd

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Living Cell Technologies Limited was founded in 1987 and is based in Auckland, New Zealand. The Company is an Australian biotechnology. It is engaged in the clinical development of cell-based therapeutics for the treatment of diabetes, and pre-clinical research and development into neurological disorders. The Company focuses on developing treatments for implanting healthy living cells to replace or repair disease or damaged organs, for a range of life-threatening diseases, and also focuses on a treatment for Type 1 diabetes. The Company's products include DIABECELL, NTCELL, Fac8Cell, Porcine Tissues and Encapsulation Technology. DIABECELL is a porcine insulin-producing cell product that is in Phase IIb clinical trial for the treatment of Type 1 diabetes; NTCELL is a choroid plexus cell product to treat neurodegenerative diseases; and IMMUPEL isolates the transplanted cells from the patient's immune system and eliminates the need for toxic immunosuppressant drugs.

Key Statistics

Overview:

Short Volume Ratio 1.00

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ 0 K

Growth:

1-Year Return 54.90%
3-Year Return -21.00%
5-Year Return 0.00%

Per-Share Information:

Next Earnings Date N/A
Dividend Payout Ratio 0.00%

LVCLF Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % N/A
Return-on-Assets % N/A
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 3.23
Book Value/Share N/A
Interest Coverage N/A
60-Month Beta N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar